Remdesivir is the only drug the FDA has given full approval to for treating COVID-19, and it’s only for hospitalized patients.
Health agencies such as the FDA and private health companies across the world have worked on finding and creating effective treatments since the COVID-19 pandemic erupted in early 2020. The FDA has reviewed hundreds of drugs and researchers have put drugs through thousands of clinical trials to find which drugs might be effective in fighting COVID-19.
During that time, many drugs have looked promising in early trials only to run into issues in later trials. Some drugs have returned mixed results between trials, while other drugs have looked promising in trials with limitations or issues.
That leads to some confusing scenarios in which the public hears of a drug with early promise and then hears the same drug is ineffective just a few months later. These confusing conditions have led to the rise in public popularity for some drugs that regulators aren’t yet comfortable approving and recommending to the public. The most well-known example is hydroxychloroquine, but the most recent example is ivermectin.
Further boosting ivermectin’s popularity is an Instagram video popular podcaster Joe Rogan posted in early September describing his COVID-19 treatment of monoclonal antibodies, ivermectin, Zithromax Z-Pak Oral, prednisone and a vitamin drip.
September 13, 2021